Cargando…

Contrast weighted learning for robust optimal treatment rule estimation

Personalized medicine aims to tailor medical decisions based on patient‐specific characteristics. Advances in data capturing techniques such as electronic health records dramatically increase the availability of comprehensive patient profiles, promoting the rapid development of optimal treatment rul...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Xiaohan, Ni, Ai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826186/
https://www.ncbi.nlm.nih.gov/pubmed/36104931
http://dx.doi.org/10.1002/sim.9574
_version_ 1784866791418232832
author Guo, Xiaohan
Ni, Ai
author_facet Guo, Xiaohan
Ni, Ai
author_sort Guo, Xiaohan
collection PubMed
description Personalized medicine aims to tailor medical decisions based on patient‐specific characteristics. Advances in data capturing techniques such as electronic health records dramatically increase the availability of comprehensive patient profiles, promoting the rapid development of optimal treatment rule (OTR) estimation methods. An archetypal OTR estimation approach is the outcome weighted learning, where OTR is determined under a weighted classification framework with clinical outcomes as the weights. Although outcome weighted learning has been extensively studied and extended, existing methods are susceptible to irregularities of outcome distributions such as outliers and heavy tails. Methods that involve modeling of the outcome are also sensitive to model misspecification. We propose a contrast weighted learning (CWL) framework that exploits the flexibility and robustness of contrast functions to enable robust OTR estimation for a wide range of clinical outcomes. The novel value function in CWL only depends on the pairwise contrast of clinical outcomes between patients irrespective of their distributional features and supports. The Fisher consistency and convergence rate of the estimated decision rule via CWL are established. We illustrate the superiority of the proposed method under finite samples using comprehensive simulation studies with ill‐distributed continuous outcomes and ordinal outcomes. We apply the CWL method to two datasets from clinical trials on idiopathic pulmonary fibrosis and COVID‐19 to demonstrate its real‐world application.
format Online
Article
Text
id pubmed-9826186
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-98261862023-01-09 Contrast weighted learning for robust optimal treatment rule estimation Guo, Xiaohan Ni, Ai Stat Med Research Articles Personalized medicine aims to tailor medical decisions based on patient‐specific characteristics. Advances in data capturing techniques such as electronic health records dramatically increase the availability of comprehensive patient profiles, promoting the rapid development of optimal treatment rule (OTR) estimation methods. An archetypal OTR estimation approach is the outcome weighted learning, where OTR is determined under a weighted classification framework with clinical outcomes as the weights. Although outcome weighted learning has been extensively studied and extended, existing methods are susceptible to irregularities of outcome distributions such as outliers and heavy tails. Methods that involve modeling of the outcome are also sensitive to model misspecification. We propose a contrast weighted learning (CWL) framework that exploits the flexibility and robustness of contrast functions to enable robust OTR estimation for a wide range of clinical outcomes. The novel value function in CWL only depends on the pairwise contrast of clinical outcomes between patients irrespective of their distributional features and supports. The Fisher consistency and convergence rate of the estimated decision rule via CWL are established. We illustrate the superiority of the proposed method under finite samples using comprehensive simulation studies with ill‐distributed continuous outcomes and ordinal outcomes. We apply the CWL method to two datasets from clinical trials on idiopathic pulmonary fibrosis and COVID‐19 to demonstrate its real‐world application. John Wiley & Sons, Inc. 2022-09-14 2022-11-30 /pmc/articles/PMC9826186/ /pubmed/36104931 http://dx.doi.org/10.1002/sim.9574 Text en © 2022 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Guo, Xiaohan
Ni, Ai
Contrast weighted learning for robust optimal treatment rule estimation
title Contrast weighted learning for robust optimal treatment rule estimation
title_full Contrast weighted learning for robust optimal treatment rule estimation
title_fullStr Contrast weighted learning for robust optimal treatment rule estimation
title_full_unstemmed Contrast weighted learning for robust optimal treatment rule estimation
title_short Contrast weighted learning for robust optimal treatment rule estimation
title_sort contrast weighted learning for robust optimal treatment rule estimation
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826186/
https://www.ncbi.nlm.nih.gov/pubmed/36104931
http://dx.doi.org/10.1002/sim.9574
work_keys_str_mv AT guoxiaohan contrastweightedlearningforrobustoptimaltreatmentruleestimation
AT niai contrastweightedlearningforrobustoptimaltreatmentruleestimation